» Articles » PMID: 30825056

Cause and Effect of Microenvironmental Acidosis on Bone Metastases

Overview
Specialty Oncology
Date 2019 Mar 3
PMID 30825056
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal involvement is a frequent and troublesome complication in advanced cancers. In the process of tumor cells homing to the skeleton to form bone metastases (BM), different mechanisms allow tumor cells to interact with cells of the bone microenvironment and seed in the bone tissue. Among these, tumor acidosis has been directly associated with tumor invasion and aggressiveness in several types of cancer although it has been less explored in the context of BM. In bone, the association of local acidosis and cancer invasiveness is even more important for tumor expansion since the extracellular matrix is formed by both organic and hard inorganic matrices and bone cells are used to sense protons and adapt or react to a low pH to maintain tissue homeostasis. In the BM microenvironment, increased concentration of protons may derive not only from glycolytic tumor cells but also from tumor-induced osteoclasts, the bone-resorbing cells, and may influence the progression or symptoms of BM in many different ways, by directly enhancing cancer cell motility and aggressiveness, or by modulating the functions of bone cells versus a pro-tumorigenic phenotype, or by inducing bone pain. In this review, we will describe and discuss the cause of acidosis in BM, its role in BM microenvironment, and which are the final effectors that may be targeted to treat metastatic patients.

Citing Articles

Modelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy.

Suurmond C, Leeuwenburgh S, van den Beucken J Cell Prolif. 2024; 57(9):e13693.

PMID: 38899562 PMC: 11503253. DOI: 10.1111/cpr.13693.


Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study.

Zhang W, Shao Z Front Endocrinol (Lausanne). 2023; 14:1289319.

PMID: 38027171 PMC: 10663373. DOI: 10.3389/fendo.2023.1289319.


The Prognostic Value of the Serum Level of C-Reactive Protein for Survival of Children with Ewing's Sarcoma.

Errani C, Traversari M, Cosentino M, Manfrini M, Basoli S, Tsukamoto S Cancers (Basel). 2023; 15(5).

PMID: 36900365 PMC: 10000755. DOI: 10.3390/cancers15051573.


Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory neurons via GPR81.

Okui T, Hiasa M, Hasegawa K, Nakamura T, Ono K, Ibaragi S Int J Oncol. 2023; 62(3).

PMID: 36799150 PMC: 9946803. DOI: 10.3892/ijo.2023.5487.


Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases.

Di Pompo G, Kusuzaki K, Ponzetti M, Leone V, Baldini N, Avnet S Biomedicines. 2022; 10(8).

PMID: 36009451 PMC: 9405350. DOI: 10.3390/biomedicines10081904.


References
1.
Yoneda T, Hiasa M, Okui T . Crosstalk Between Sensory Nerves and Cancer in Bone. Curr Osteoporos Rep. 2018; 16(6):648-656. DOI: 10.1007/s11914-018-0489-x. View

2.
Toyomura T, Murata Y, Yamamoto A, Oka T, Sun-Wada G, Wada Y . From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation. J Biol Chem. 2003; 278(24):22023-30. DOI: 10.1074/jbc.M302436200. View

3.
Silver I, Murrills R, Etherington D . Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988; 175(2):266-76. DOI: 10.1016/0014-4827(88)90191-7. View

4.
Kolosenko I, Avnet S, Baldini N, Viklund J, De Milito A . Therapeutic implications of tumor interstitial acidification. Semin Cancer Biol. 2017; 43:119-133. DOI: 10.1016/j.semcancer.2017.01.008. View

5.
Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View